Filing Details

Accession Number:
0001225208-10-005416
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-24 12:00:00
Reporting Period:
2010-02-22
Filing Date:
2010-02-24
Accepted Time:
2010-02-24 11:07:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
732485 Genzyme Corp GENZ Biological Products, (No Disgnostic Substances) (2836) 061047163
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021038 A Henri Termeer 500 Kendall Street
Cambridge MA 02142
Chmn, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Genzyme Common Stock (Genz) Acquisiton 2010-02-22 100,000 $26.50 724,630 No 4 M Direct
Genzyme Common Stock (Genz) Disposition 2010-02-22 100,000 $55.78 624,630 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Genzyme Common Stock (Genz) Stock Option (right to buy) Disposition 2010-02-22 100,000 $26.50 100,000 $26.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 2002-02-28 2010-05-25 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Genzyme Common Stock (Genz) 18,360 Indirect By 401(k)
Genzyme Common Stock (Genz) 2,371 Indirect By Spouse
Genzyme Common Stock (Genz) 1,256 Indirect By Trust
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 23, 2009.